Cytokines | Cataract (n = 20) | nAMD, baseline (n = 20) | nAMD, at month 1 (n = 20) | nAMD, at month 2 (n = 20) | ||||
---|---|---|---|---|---|---|---|---|
Mean ± SD (pg/ml) | Mean ± SD (pg/ml) | P-Value (vs. cataract) | Mean ± SD (pg/ml) | P-Value (vs. cataract) | Mean ± SD (pg/ml) | P-Value (vs. cataract) | P-Value (vs. baseline) | |
Angiogenina | 24,317.3 ± 4154.7 | 30,190.6 ± 3476.4 | 0.01584b | 29,507.4 ± 4350.8 | 0.02178b | 29,965.3 ± 2967.4 | 0.01380b | 1 |
BMP-9a | 3.0 ± 0.2 | 3.2 ± 0.2 | 0.09101 | 3.2 ± 0.3 | 0.02178b | 3.1 ± 0.3 | 0.09036 | 1 |
CCL1/I-309a | 1.0 ± 0.3 | 1.4 ± 0.24 | 0.09101 | 1.7 ± 0.8 | 0.06525 | 1.4 ± 0.4 | 0.23958 | 1 |
CCL13/MCP-4a | 6.6 ± 0.9 | 7.9 ± 1.5 | 0.06545 | 8.0 ± 1.9 | 0.03600b | 7.5 ± 1.6 | 0.26987 | 1 |
CCL2/MCP-1a | 660.3 ± 217.6 | 1029.6 ± 1214.8 | 0.25202 | 1080.2 ± 1392.7 | 0.06825 | 869.2 ± 630.3 | 0.26987 | 1 |
CXCL10/IP-10a | 27.3 ± 13.9 | 48.2 ± 41.2 | 0.09101 | 43.8 ± 22.1 | 0.03600b | 36.5 ± 22.8 | 0.51063 | 1 |
CXCL2/GRO βa | 121.7 ± 24.2 | 128.5 ± 11.2 | 0.16895 | 128.6 ± 24.3 | 0.54896 | 130.6 ± 15.7 | 0.03866b | 1 |
CXCL8/IL-8a | 61.2 ± 11.0 | 84.4 ± 45.8 | 0.03920b | 80.2 ± 30.9 | 0.06825 | 76.6 ± 16.3 | 0.05919 | 1 |
Endothelin-1a | 33.4 ± 2.6 | 37.1 ± 6.6 | 0.48126 | 37.8 ± 6.3 | 0.02547b | 35.8 ± 6.1 | 1 | 1 |
FGF acidica | 22.7 ± 3.3 | 26.8 ± 2.3 | 0.03920b | 28.6 ± 6.7 | 0.03600b | 28.2 ± 7.6 | 0.00369b | 1 |
IL-15a | 4.9 ± 1.8 | 6.1 ± 1.7 | 0.16895 | 6.4 ± 2.5 | 0.06525 | 6.0 ± 1.9 | 0.95610 | 1 |
IL-22a | 21.0 ± 3.8 | 23.4 ± 2.9 | 0.09101 | 24.0 ± 3.6 | 0.03394b | 23.0 ± 2.6 | 0.11419 | 1 |
IL-36 β/IL-1F8a | 1.1 ± 0.7 | 1.5 ± 0.3 | 0.03920b | 1.6 ± 0.7 | 0.02613b | 1.5 ± 0.4 | 0.01634b | 1 |
PDGF-BBa | 1.7 ± 0.5 | 2.4 ± 1.0 | 0.06545 | 2.3 ± 0.9 | 0.03600b | 2.1 ± 0.6 | 0.47894 | 1 |
PlGFa | 4.9 ± 0.5 | 5.3 ± 0.9 | 0.06545 | 4.9 ± 1.1 | 1 | 4.7 ± 1.2 | 1 | 0.02070b |
TNF-αa | 2.1 ± 0.6 | 2.4 ± 0.4 | 0.16895 | 2.8 ± 1.3 | 0.02613b | 2.4 ± 0.5 | 0.70739 | 1 |
VEGF-Aa | 72.0 ± 21.6 | 70.6 ± 30.5 | 1 | 22.5 ± 1.7 | 0.00010b | 22.3 ± 1.0 | 2.88 × 10−5b | 0.00010b |
VEGF-Ca | 303.3 ± 47.0 | 327.0 ± 24.0 | 0.05820 | 329.5 ± 39.0 | 0.03600b | 317.5 ± 35.2 | 0.45039 | 1 |
Angiopoietin-1 | 105.4 ± 35.3 | 127.1 ± 67.6 | – | 126.2 ± 76.1 | – | 116.4 ± 56.2 | – | – |
Angiopoietin-2 | 84.2 ± 16.8 | 107.1 ± 56.5 | – | 104.2 ± 57.9 | – | 101.8 ± 60.7 | – | – |
CCL20/MIP-3 α | 20.9 ± 12.1 | 20.4 ± 10.7 | – | 17.8 ± 8.9 | – | 15.5 ± 7.7 | – | – |
CCL27/CTACK | 4.5 ± 2.1 | 5.5 ± 1.9 | – | 5.5 ± 2.2 | – | 5.2 ± 2.4 | – | – |
CRP | 49,709.8 ± 186,176.6 | 7566.9 ± 9756.9 | – | 7132.9 ± 8391.2 | – | 9574.2 ± 20,248.2 | – | – |
CXCL16 | 609.5 ± 132.1 | 740.2 ± 314.7 | – | 759.4 ± 324.7 | – | 739.9 ± 322.5 | – | – |
Endocan/ESM-1 | 113.8 ± 35.3 | 127.6 ± 46.1 | – | 132.4 ± 51.0 | – | 126.0 ± 58.0 | – | – |
FGF basic | 17.4 ± 5.3 | 17.6 ± 6.0 | – | 16.9 ± 6.5 | – | 14.5 ± 3.9 | – | – |
IL-6 | 8.9 ± 24.1 | 3.3 ± 5.5 | – | 6.1 ± 17.3 | – | 3.9 ± 3.8 | – | – |
PDGF-AA | 37.6 ± 8.8 | 42.2 ± 10.7 | – | 41.6 ± 13.5 | – | 41.1 ± 12.9 | – | – |